AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35

Authors: Wilcox, MH Subramanian, D
Citation: Mh. Wilcox et D. Subramanian, Diagnosing genitourinary chlamydial infection - Vaginal swabs alone may not be sufficient, BR MED J, 323(7311), 2001, pp. 515-515

Authors: Wilcox, MH Dave, J
Citation: Mh. Wilcox et J. Dave, Treatment options in Clostridium difficile infection, REV MED MIC, 12(1), 2001, pp. 21-28

Authors: Fawley, WN Wilcox, MH
Citation: Wn. Fawley et Mh. Wilcox, Molecular epidemiology of endemic Clostridium difficile infection, EPIDEM INFE, 126(3), 2001, pp. 343-350

Authors: Brazier, JS Fawley, W Freeman, J Wilcox, MH
Citation: Js. Brazier et al., Reduced susceptibility of Clostridium difficile to metronidazole, J ANTIMICRO, 48(5), 2001, pp. 741-742

Authors: Heritage, J Ransome, N Chambers, PA Wilcox, MH
Citation: J. Heritage et al., A comparison of culture and PCR to determine the prevalence of ampicillin-resistant bacteria in the faecal flora of general practice patients, J ANTIMICRO, 48(2), 2001, pp. 287-289

Authors: Wilcox, MH Fawley, W
Citation: Mh. Wilcox et W. Fawley, Extremely low prevalence of UK Staphylococcus aureus isolates with reducedsusceptibility to vancomycin - J Antimicrob Chemother 2001; 48 : 144-145, J ANTIMICRO, 48(1), 2001, pp. 144-145

Authors: Wilcox, MH Brown, A Freeman, J
Citation: Mh. Wilcox et al., Faecal concentrations of piperacillin and tazobactam in elderly patients -J Antimicrob Chemother 2001; 48 : 155-156, J ANTIMICRO, 48(1), 2001, pp. 155-156

Authors: Freeman, J Wilcox, MH
Citation: J. Freeman et Mh. Wilcox, Ureidopenicillins and risk of Clostridium difficile infection - J Antimicrob Chemother 2001; 47 : 719, J ANTIMICRO, 47(5), 2001, pp. 719-719

Authors: Wilcox, MH
Citation: Mh. Wilcox, Clarithromycin and risk of Clostridium difficile-associated diarrhoea, J ANTIMICRO, 47(3), 2001, pp. 358-359

Authors: Wilcox, MH Kite, P Mills, K Sugden, S
Citation: Mh. Wilcox et al., In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm, J ANTIMICRO, 47(2), 2001, pp. 171-175

Authors: Freeman, J Wilcox, MH
Citation: J. Freeman et Mh. Wilcox, Antibiotic activity against genotypically distinct and indistinguishable Clostridium difficile isolates, J ANTIMICRO, 47(2), 2001, pp. 244-246

Authors: Verity, P Wilcox, MH Fawley, W Parnell, P
Citation: P. Verity et al., Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms, J HOSP INF, 49(3), 2001, pp. 204-209

Authors: Parnell, P Wilcox, MH
Citation: P. Parnell et Mh. Wilcox, Mycobacterium chelonae and Acremonium species isolated from endoscope autodisinfector rinse water despite daily treatment with chlorine dioxide, J HOSP INF, 48(2), 2001, pp. 152-154

Authors: Wilcox, MH Fawley, WN
Citation: Mh. Wilcox et Wn. Fawley, Virulence of Clostridium difficile toxin A negative strains, J HOSP INF, 48(1), 2001, pp. 81-81

Authors: Wilcox, MH
Citation: Mh. Wilcox, Uses of error: Microbial perils, LANCET, 358(9277), 2001, pp. 237-237

Authors: Modi, N Wilcox, MH
Citation: N. Modi et Mh. Wilcox, Evidence for antibiotic induced Clostridium perfringens diarrhoea, J CLIN PATH, 54(10), 2001, pp. 748-751

Authors: Wilcox, MH Reynolds, MT Hoy, CM Brayson, J
Citation: Mh. Wilcox et al., Combined cervical swab and urine specimens for PCR diagnosis of genital Chlamydia trachomatis infection, SEX TRANS I, 76(3), 2000, pp. 177-178

Authors: Wilcox, MH Modi, N
Citation: Mh. Wilcox et N. Modi, Meningococcal disease in healthcare workers - Ceftriaxone may be helpful, BR MED J, 320(7229), 2000, pp. 248-248

Authors: Wilcox, MH Fitzgerald, P Freeman, J Denton, M Gill, AB Hoy, C Parnell, P Porter, C Haspinall, L Hawkey, P
Citation: Mh. Wilcox et al., A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit, EPIDEM INFE, 124(1), 2000, pp. 37-45

Authors: Wilcox, MH Fawley, W Freeman, J Brayson, J
Citation: Mh. Wilcox et al., In vitro activity of new generation fluoroquinolones against genotypicallydistinct and indistinguishable Clostridium difficile isolates, J ANTIMICRO, 46(4), 2000, pp. 551-555

Authors: Wilcox, MH Dave, J
Citation: Mh. Wilcox et J. Dave, The cost of hospital-acquired infection and the value of infection control, J HOSP INF, 45(2), 2000, pp. 81-84

Authors: Wilcox, MH Fawley, WN Parnell, P
Citation: Mh. Wilcox et al., Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile, J HOSP INF, 44(1), 2000, pp. 65-69

Authors: Wilcox, MH Fawley, WN
Citation: Mh. Wilcox et Wn. Fawley, Hospital disinfectants and spore formation by Clostridium difficile, LANCET, 356(9238), 2000, pp. 1324-1324

Authors: Wilcox, MH
Citation: Mh. Wilcox, Respiratory antibiotic use and Clostridium difficile infection: is it the drugs or is it the doctors?, THORAX, 55(8), 2000, pp. 633-634

Authors: Freeman, J Wilcox, MH
Citation: J. Freeman et Mh. Wilcox, Antibiotics and Clostridium difficile, MICROBES IN, 1(5), 1999, pp. 377-384
Risultati: 1-25 | 26-35